Get the full picture
Sign in to uncover key details.
ImmunoBrain Checkpoint
Manufacturing · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3 Haim Pekeris St, Rechovot, Central Dis...Website
www.immunobrain.comRevenue
<$5 MillionIndustry
About ImmunoBrain Checkpoint
ImmunoBrain is dedicated to transforming the understanding and treatment of neurodegenerative disorders by leveraging the body's peripheral immune system to address brain pathology. The company is currently focused on its lead program, IBC-Ab002, a novel anti-PD-L1 antibody, which is being investigated in clinical trials for early Alzheimer's disease. With a unique approach to the communication between the peripheral immune system and the brain, ImmunoBrain aims to redefine treatment strategies for neurological conditions. Their innovative research and clinical trials position them as a leader in the field of neurodegeneration.Explore more
ImmunoBrain Checkpoint Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
ImmunoBrain Checkpoint Tech Stack
A closer look at the technologies used by ImmunoBrain Checkpoint
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ImmunoBrain Checkpoint
Sign Up For FreeTo access detailed company insights
ImmunoBrain is dedicated to transforming the understanding and treatment of neurodegenerative disorders by leveraging the body's peripheral immune system to address brain pathology. The company is currently focused on its lead program, IBC-Ab002, a novel anti-PD-L1 antibody, which is being investigated in clinical trials for early Alzheimer's disea... Read More
